Answers are grounded in this paper and cite their sources.
Cucurbitacins, widely found in plants belonging to the family of Cucurbitaceae, are highly oxidized tetracyclic triterpenes with various bioactivities, such as anticancer, anti-inflammatory, and liver protection. Among which, the anticancer activity of cucurbitacins is well studied. Cucurbitacins have been reported to promote apoptosis through the JAK/STAT3 pathway and the MAPK pathway. Cucurbitacins can block the cell cycle by inhibiting cyclins. They also accelerate autophagy and inhibit the invasion and migration of cancer cells. Numerous studies have demonstrated that cucurbitacins exhibit a synergistic effect in the combination with small-molecule drugs. This paper reviews the bioactivities of cucurbitacins, preferably anticancer activity. Herein, the synergistic effect of the combination of cucurbitacins and small-molecule drugs has also been summarized with the aim to promote the probability of the use of cucurbitacins as adjunct drugs in clinical treatment.
No takes yet. Share an insight, caveat, or question.
Jing et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: